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Abstract
Background: Thyroid hormones (THs) regulate many biological functions in the human body and are essential for
normal brain development. Epidemiological studies have observed diverging associations between halogenated
persistent organic pollutant (POP) exposure and concentrations of THs in pregnant women and their infants. We
investigated whether background exposure to polybrominated diphenyl ethers (PBDEs) is related to TH status in a
Swedish population of pregnant women and their infants. Furthermore, we examined associations between
polychlorinated dibenzo-p-dioxins/dibenzofurans (PCDD/Fs) and polychlorinated biphenyls (PCBs) and TH status
in early pregnancy as an extension of an earlier study focusing on late pregnancy TH status.
Methods: Free thyroxine (T4), total triiodo-thyronine (T3) and thyroid stimulating hormone (TSH) were analysed in
serum from first-time mothers (N = 220-281) in the first and third trimester, and in infants (N = 115-150) 3 weeks and
3 months after delivery. Antibodies to thyroid peroxidase (anti-TPO) (N = 260) were measured in maternal third
trimester serum. Maternal body burdens of PCBs (N = 281) were estimated from serum lipid PCB concentrations in late
pregnancy, and PCDD/F (N = 97) and PBDE (N = 186) body burdens were estimated from concentrations in mother’s
milk lipids 3 weeks after delivery. Linear regression models allowed for covariate adjustment of the associations
between ln-transformed POP body burdens and concentrations of TH and anti-TPO.
Results: Maternal body burden of BDE-153 was inversely associated with first trimester total T3, otherwise no associations
between PBDEs and first and second trimester THs were observed. No associations were found between maternal PBDE
body burdens and infant THs. Maternal body burden of PCDD/Fs were inversely associated with first trimester total T3. No
associations were observed between PCBs and first trimester THs. Third trimester anti-TPO was not associated with
maternal PCBs, PCDD/Fs and PBDEs.
Conclusions: Our results suggest that maternal PCDD/F and BDE-153 body burdens influence maternal TH status in early
pregnancy, which is a critical period when maternal TH status influences fetal development.
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Background
Thyroid hormones (THs) regulate a wide array of biological
functions in the human body, including metabolism and
development. THs are essential for normal brain develop-
ment, particularly during the fetal period [1]. Severe mater-
nal and congenital hypothyroidism is associated with
impaired child neurodevelopment, and hypothyroid fetuses
suffer various postnatal disorders including mental retard-
ation, deafness and spasticity [2]. Even relatively minor
reductions in maternal free thyroxine (T4) blood concen-
trations in early pregnancy, with normal thyroid stimulating
hormone (TSH) concentrations, have been associated with
impaired cognitive development among children [2]. How-
ever, THs play many other roles during pregnancy, for
instance by local action of THs on female reproductive
organs and embryo during implantation [3, 4]. Moreover,
THs are essential for normal fetal growth [5]. It has been
suggested that any alteration in maternal and fetal thyroid
function has implications for health of both the fetus and
mother [3, 5].
Several halogenated persistent organic pollutants (POPs)
have chemical structures similar to THs, and there are
many studies of POP-induced TH disruption in laboratory
animals. Polychlorinated dibenzo-p-dioxins and poly-
chlorinated dibenzofurans (PCDD/Fs), polychlorinated
biphenyls (PCBs) and polybrominated diphenyl ethers
(PBDEs) reduce the concentrations of circulating free and
total thyroxine (T4) in animals. In some studies PCBs and
PCDD/Fs have increased the concentrations of thyroid
stimulating hormone (TSH) [4, 6], suggesting a feedback
response to stimulate TH production.
Epidemiological studies on associations between back-
ground exposure of pregnant women and their infants
to PCDD/Fs and PCBs and blood concentrations of THs
indicate inverse associations with triiodothyronine (T3)
or T4 and in some cases positive associations with TSH
[7–11]. Conflicting results or absence of significant asso-
ciations have also been reported [12–15]. Studies on
associations between exposure to PBDEs and TH con-
centrations in pregnant women and infants are still lim-
ited. The results are inconclusive and indicate inverse or
positive associations, as well as no statistically significant
associations [14, 16–22].
The aim of the present study was to investigate associa-
tions between background maternal body burdens of
PCBs and PCDD/Fs during pregnancy and first trimester
maternal TH concentrations in a cohort of Swedish
mother-infant pairs (POPUP cohort; Persistent Organic
Pollutants in Uppsala Primiparas). Many previous studies
have measured third trimester THs [8, 9, 23]. In the
current study we considered it relevant to study maternal
TH concentrations in early pregnancy, since the fetus is
dependent on maternal THs during this period for normal
development [5]. Since we previously investigated
associations between maternal PCB/PCDD/F body bur-
dens and TH in late pregnancy in the same women [24],
we now also have the possibility to determine if associa-
tions persist from the first to the third trimester, or if asso-
ciations differ between the two time-points. In the earlier
study we found an inverse association between maternal
body burdens of PCDD/F and total T3 in late pregnancy.
No significant associations were found for PCBs [24].
In the POPUP cohort we have previously observed an
inverse association between maternal body burden of
sumPBDE (BDE-47, 99-, −100 and −153) and birth weight
[25]. Maternal TH status during pregnancy is an import-
ant determining factor for fetal growth [5], and PBDE-
induced alterations in TH status could be a mechanism
behind our PBDE/birth weight observation [25]. In the
current study we therefore examined associations between
maternal body burdens of tetra- to hexa-brominated
PBDEs and maternal first and third trimester TH concen-
trations, in an effort to shed a light on possible effects of
background PBDE exposure on maternal thyroid function.
PBDEs were not investigated in our previous study [24].
In the current study we also investigated associations be-
tween maternal PBDE and THs in 3 weeks and 3 months
old infants. In the previous study, not including PBDEs,
no associations were observed between maternal PCDD/
Fs and PCBs and THs in 3-weeks and 3-months old
infants [24].
Finally, in the present study we investigated associations
between maternal PCDD/F, PCB and PBDE body burdens
and maternal third trimester concentrations of antibodies
to thyroid peroxidase (anti-TPO), a useful biomarker of
thyroid dysfunction. Only a few studies have addressed
the possibility that POPs may cause thyroid dysfunction
through anti-TPO. A study in a highly PCB polluted area
in Slovakia showed a positive association between PCB
body burdens in adults and anti-TPO [26]. In an adult
population with background PCB exposure in Italy no sig-
nificant association was found [27].
Methods
Study population, sampling and data collection
The POPUP study is an on-going study that includes ran-
domly selected first-time mothers from Uppsala County,
Sweden [28, 29]. During the first years of the study (1996–
1999), 325 pregnant women were recruited [30]. Partici-
pants donated non-fasting blood samples in early (first tri-
mester, week 6–12) and late (third trimester, week 32–34)
pregnancy. After delivery, mother’s milk was donated by
204 women and blood was sampled from 160 infants at
3 weeks and from 138 infants at 3 months of age. The
milk sampling was conducted at home during the third
week after delivery.
The present study of THs includes 307 mother-infant
pairs recruited in 1996–99, of which 196 donated
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mother’s milk. Due to limited blood serum volumes in
the present study, first trimester THs were analysed in
220 maternal blood serum samples. TH data from the
third trimester, and from infants 3 weeks (N = 150) and
3 months (N = 115) after delivery, were taken from the
previous study [24]. Concentrations of anti-TPO were in
the present study determined in third trimester maternal
serum (N = 260). PCB concentrations in maternal third
trimester serum were obtained from the previous study
[24], as well as mother’s milk data on PCDD/Fs. PBDEs
were analysed in mother’s milk in the present study.
Data on maternal and child characteristics were obtained
from interviews, questionnaires and from the Swedish
Medical Birth Register at the National Board of Health
and Welfare [25, 30]. The study was approved by the
local ethics committee of Uppsala University (reference
number 96114 and 2004:M-177), and participants gave




Non-fasting serum concentrations of total T3, free T4 and
TSH were measured on an automatic immunoassay system
(Autodelfia, Wallac Oy, Turku, Finland). In the present
study THs from the first trimester were analysed in
addition to the third trimester TH analysis from the previ-
ous study [24], using the same analytical method. Moreover,
total T3 free T4 and TSH data for infants (3 weeks and
3 months) were available from the previous study [24], also
using the same analytical methods as in the present study.
In the present study, measurements of anti-TPO in third
trimester serum were performed on an automatic immun-
ology analyser (Cobas E601, Roche Diagnostics, Basel,
Switzerland). The total assay variation in the individual as-
says was less than 5 %. All analyses were performed at the
routine laboratory of the Department of Clinical Chemistry
at the University Hospital in Uppsala. The laboratory is cer-
tified by a Swedish government authority (Swedac).
POP in blood serum and mother’s milk
Blood serum samples collected in the third trimester were
in the previous study analysed for di-ortho substituted
PCB congeners (PCB 138, 153 and 180) and mono-ortho
substituted PCB congeners (PCB 105, 118, 156 and 167)
(N = 281) [24]. A randomly selected number of mother’s
milk samples were at the same time analysed for seven-
teen 2,3,7,8-substituted PCDD/Fs (N = 97) [24]. In
addition, in the present study four PBDE-congeners
(BDE-47, BDE-99, BDE-100, BDE-153) (N = 186) were
analysed in mother’s milk.
PCBs in blood serum and PBDEs in mother’s milk were
analysed at the Swedish National Food Agency (NFA) ac-
cording to previously described methods [29, 30]. After
extraction and clean-up, the quantification of PCBs was
performed on a gas chromatograph equipped with dual
capillary columns and electron capture detectors (63Ni)
[28]. PBDEs were analysed by gas chromatography/low
resolution mass spectroscopy/electron capture negative
ionization and detected by single ion monitoring tech-
nique [28]. All samples were fortified with internal stan-
dards prior to extraction to correct for analytical losses
and to ensure quality control. The limit of quantification
(LOQ) varied between 2 and 4 ng/g lipid for PCBs and
between 0.1 and 1.3 ng/g lipid for PBDE congeners.
PCDD/Fs in mother’s milk was analysed at the National
Institute of Public Health and the Environment (RIVM),
the Netherlands, using a method earlier described [28, 31].
Briefly, samples were analysed according to validated
procedures consisting of milk extraction, several clean-up
steps including active carbon chromatography, and identi-
fication and quantification of the analytes using gas chro-
matography with high-resolution mass spectrometry with
isotope dilution technique. LOQ varied between 0.1 and
1.0 pg/g lipids for the individual PCDD/F congeners.
The lipid content of each mother’s milk and blood
serum sample was determined gravimetrically. A number
of control samples were analysed together with the sam-
ples to verify the accuracy and precision of measurements.
The laboratories at the NFA and RIVM have successfully
participated in several international proficiency tests.
Data analysis
Estimation of exposure
Lipid-adjusted maternal blood serum concentrations
(PCBs) or mother’s milk concentrations (PCDD/Fs,
PBDEs) were used to estimate maternal body burdens
during pregnancy as well as fetal exposure. When the
concentrations were below the LOQ, half of LOQ was
taken as an estimated value. POPs were grouped into di-
ortho PCBs (sum of PCB 138, 153 and 180), mono-ortho
PCB TEQ (toxic equivalents) (sum of TEQs for PCB
105, 118, 156 and 167), PCDD/F TEQ (sum of TEQs for
17 PCDD/F congeners), and tetra-pentaPBDE (sum of
BDE-47, −99 and −100). The hexa-brominated BDE-153
was treated separately in the statistical analyses since the
tetra-pentaPBDEs are strongly correlated with each
other, but not with BDE-153 in mother’s milk in the
POPUP cohort [29]. Moreover, BDE-153 seems to devi-
ate from the lower brominated PBDEs with regards to
toxicokinetics [29]. For the dioxin-like PCBs and PCDD/
Fs, the WHO 2005 toxic equivalency factor (TEF) sys-
tem was used when the concentrations of the substances
were combined [32].
Statistical models
In the current study we investigated associations between
maternal body burdens of PCBs (maternal serum), PCDD/
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Fs and PBDEs (mother’s milk) and first trimester TH con-
centrations. In addition, associations between maternal
PBDE body burdens and maternal TH concentrations in
the third trimester, as well as infant TH concentrations
3 weeks and 3 months after delivery, were studied. Finally,
associations between all analysed POPs and maternal third
trimester concentrations of anti-TPO were assessed.
Statistical analyses were performed using MINITAB
15® Statistical Software for Windows. A p-value ≤0.05
was considered statistically significant in all statistical
tests. We used linear regression models to investigate as-
sociations between exposure to POPs and serum TH
and anti-TPO concentrations. To reduce the effect of
outliers, and to get normally distributed exposure data,
all POP concentrations were ln-transformed. Total T3,
free T4 and TSH concentrations were approximately
normally distributed (Shapiro-Wilk W-test, W = 0.86-
0.99). However, anti-TPO concentrations were right-
skewed and were thus ln-transformed. After a crude
analysis, possible confounders considered for inclusion
in the maternal TH models were maternal age, country
of birth, pre-pregnancy BMI, education, smoking during
pregnancy, alcohol consumption during pregnancy,
maternal weight gain during pregnancy and season of
sampling. In addition, variables considered for inclusion
in infant TH models were gestational length, mode of
delivery, gender of the infant, birth weight, sampling day
(number of days after delivery) and infant weight at
3 months. Associations between the possible confounders
and outcomes were first investigated in bivariate models
(Pearson correlation analysis or one-way analysis of vari-
ance (ANOVA)). Covariates associated with any of the
maternal or infant outcomes (p ≤ 0.05) were included in
the final models. Covariates were included as continu-
ous variables or categorized as shown in Table 1. Sea-
son was categorized as winter (December-February),
spring (March-May), summer (June-August) and
autumn (September-November). The number of sam-
ples analysed for the different POPs varied, and ana-
lyses restricted to individuals with complete datasets
were performed to investigate if the results were robust
to changes in number of study participants. The fit of
the regression models was checked by plotting the
residuals around the fitted line. The robustness of the
results was also evaluated by a sensitivity analysis where
outliers with a standardized residual ≥3 were excluded
from the regression models.
Results
Characteristics of the participating women and children
as well as blood serum concentrations of THs are given
in Table 1. PCB concentrations in maternal blood serum
and breast milk PCDD/F and PBDE concentrations are
presented in Table 2. In blood serum, di-ortho PCBs was
the substance group with the highest median concentra-
tion (128 ng/g lipid). The median concentration of
PCDD/F TEQ in mother’s milk was 7.9 pg/g lipid. BDE-
47 was the dominating PBDE-congener with a median
mother’s milk concentration of 1.6 ng/g lipid.
In the crude analysis, there were significant inverse as-
sociations between di-ortho PCB and mono-ortho PCB
TEQ concentrations in serum lipids (third trimester)
and first trimester maternal serum concentrations of
total T3 (Table 3). Similar associations were also
observed for PCDD/F and BDE-153 in mother’s milk
lipids. Associations between tetra-pentaPBDEs and THs
were not statistically significant. After covariate adjust-
ment, the associations remained significant for PCDD/F
TEQ and BDE-153 (Table 3). There were no outliers in
the adjusted analysis of association between PCDD/F
TEQ and total T3. When three outliers were excluded
from the PBDE dataset, the association between BDE-
153 and total T3 did not change considerably (β = −0.25,
SE = 0.07, p = 0.001). In analyses restricted to individuals
with data on PCDD/F, adjusted associations between
total T3 and di-ortho PCB and mono-ortho PCB TEQ
were still non-significant (results not shown). The as-
sociation between total T3 and BDE-153 remained
significantly inverse (β = −0.35, p = 0.006). There were
no significant associations between PCDD/Fs, PCBs
and PBDEs in serum or mother’s milk lipids and first
trimester maternal serum concentrations of free T4 or
TSH (Table 3).
No associations were found between maternal
PCDD/F, PCB and PBDE concentrations in serum or
mother’s milk lipids and concentrations of anti-TPO
in late pregnancy (Table 3). Furthermore, no signifi-
cant associations between maternal PBDE concentra-
tions in mother’s milk lipids and third trimester TH
concentrations were found (Table 4). Finally, there
were no significant associations between maternal
PBDE concentrations in mother’s milk and THs in in-
fants at 3 weeks and 3 months of age (Table 5).
Discussion
The POPUP cohort includes healthy Swedish mother-
infant pairs exposed to relatively low background con-
centrations of POPs and with measured concentrations
of thyroid hormones that were generally within refer-
ence intervals [33, 34]. In the present study we found
significantly inverse associations between PCDD/F
TEQ and BDE-153 concentrations in mother’s milk
lipids and first trimester maternal concentrations of
total T3 after covariate adjustment. Our findings may
have implications for fetal development since it is
dependent on maternal first trimester THs status,
whereas the importance of fetal TH production
becomes more apparent in the second trimester. The
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Table 1 Characteristics of the study participants, i.e. 307 mother-infant pairs recruited in 1996-1999
Characteristic N Median (Range)
Maternal age (years) 307 28 (18–41)
Maternal pre-pregnancy BMI (kg/m2) 307 23 (18–44)
Maternal weight gain during pregnancy (%)a 304 22 (3.9–46)
Gestational length (days)b 138 280 (249–300)
Birth weight of the child (g)b 150 3510 (2430–5000)
Age of infant at 3-weeks-sampling (days)b 148 24 (17–38)
Weight of the infant at 3 monthsc 109 6180 (4350–8600)
Age of infant at 3-months-sampling (days)c 115 91 (75–123)
Maternal serum TH concentrations, early pregnancy
TSH (mIU/L) 220 1.3 (0.002–7.5)
Total T3 (nmol/L) 219 2.4 (0.57–3.7)
Free T4 (pmol/L) 220 11 (7.8–20)
Maternal serum TH concentrations, late pregnancy
TSH (mIU/L) 281 1.4 (0.06–6.7)
Total T3 (nmol/L) 281 2.5 (1.1–3.8)
Free T4 (pmol/L) 281 8.3 (5.7–13)
anti-TPOd (kIU/L) 260 8.6 (5.5–134)
Infant serum TH concentrations, 3 weeks of age
TSH (mIU/L) 148 2.4 (0.54–6.4)
Total T3 (nmol/L) 145 2.8 (1.4–4.2)
Free T4 (pmol/L) 150 17 (12–23)
Infant serum TH concentrations, 3 months of age
TSH (mIU/L) 115 1.8 (0.77–4.8)
Total T3 (nmol/L) 115 3.0 (1.7–4.2)
Free T4 (pmol/L) 114 15 (10–22)
N %
Country of birth
Nordic country 291 95
Non-Nordic country 16 5
Years of education
≤4 years of high school 144 49
1–3 years of higher education 72 24
>3 years of higher education 79 27
Smoking habits during pregnancy (smoker/non-smoker) 58/194 19/81
Alcohol during pregnancy (no/yes) 254/52 83/17
Mode of delivery (vaginal/caesarean)b 120/18 87/13
Sex of the child (male/female)b 83/67 55/45
a(weight gain during pregnancy/weight before pregnancy)*100
bAmong 150 infants with analysed THs in serum at 3 weeks of age
cAmong 115 infants with analysed THs in serum at 3 months
dThyroid peroxidase antibodies
Lignell et al. Environmental Health  (2016) 15:55 Page 5 of 11
PCDD/Fs results for the first trimester corroborate with
the results from the third trimester published in our
previous study [24], strongly suggesting that the de-
creased total T3 with increasing PCDD/F body burden
persisted during the whole pregnancy period.
Comparisons with results from other studies are ham-
pered by differences in study design. We could not find
other studies looking at PCDD/Fs and TH status at dif-
ferent time points during pregnancy. In a Dutch study
significantly inverse associations were reported between
PCDD/F and non/mono-ortho PCB concentrations in
mother’s milk and maternal total T3 and total T4 in late
pregnancy [9]. However, the results were not adjusted
for potential confounders, as in our study. When mater-
nal serum lipid dioxin-like PCBs concentrations were in-
cluded together with the PCDD/Fs in the present study,
using the WHO2005 TEF system [32], PCDD/F/PCB
TEQs were not associated with total T3 during the first
and third trimester (1st: β = −0.31 ± 0.22, p = 0.16, N =
64; 3rd: β = −0.15 ± 0.16, p = 0.35, N = 90). This corrobo-
rates with results from a cohort of pregnant women
from Germany, where no confounder-adjusted associ-
ation was found between serum or mother’s milk
PCDD/F + dioxin-like PCB toxicity equivalent (TEQ)
concentrations and TSH, total T4, free T4, total T3 and
free T3 concentrations in late pregnancy [13].
We observed no significant associations between the
hexa-pentaPBDEs (sum of BDE-47, −99, −100) and first
and third trimester THs in the present study. Also in
statistical analyses of individual BDE-47, −99 and −100
no significant associations were found with first and
third trimester THs (results not shown), suggesting that
tetra-pentaPBDEs do not markedly influence the TH sta-
tus of pregnant women with background exposure in
Table 2 POP concentrations in serum and mother’s milk among mothers with measured maternal and infant thyroid hormone
concentrations
Maternal Infant
N Median (range) N Median (range)
Seruma
di-ortho PCB (ng/g lipid) 281 128 (28–367)
mono-ortho PCB TEQ (pg/g lipid) 281 0.56 (0.2–3.6)
Breast milkb
PCDD/F TEQ (pg/g lipid) 91 7.9 (3.3–16)
tetra-pentaPBDE (ng/g lipid) 166 2.3 (0.46–31) 130 2.4 (0.54–31)
BDE-153 (ng/g lipid) 166 0.48 (<0.2–4.3) 130 0.49 (<0.2–2.2)
adi-ortho PCB = sum of PCB 138, 153 and 180; mono-ortho PCB TEQ = sum of TEQs for PCB 105, 118, 156 and 167 [32]
bPCDD/F TEQ = sum of TEQs for the 17 congeners with WHO TEFs [32]; tetra-pentaPBDE = sum of BDE-47, −99 and −100
Table 3 Regression coefficients (β, mean ± standard error) for associations between maternal body burdens of PCB, PCDD/F and
PBDE and first trimester thyroid hormone concentrations and third trimester thyroid peroxidase antibody (a-TPO) concentrations
Body burdensa N Total T3 Free T4 TSH a-TPOb
Unadjusted model
di-ortho PCB 219 −0.15 ± 0.06* 0.04 ± 0.25 0.08 ± 0.15 0.013 ± 0.063
mono-ortho PCB TEQ 219 −0.15 ± 0.06* 0.16 ± 0.22 0.07 ± 0.14 −0.0096 ± 0.055
PCDD/F TEQ 67 −0.55 ± 0.14* 0.10 ± 0.67 0.45 ± 0.38 0.0055 ± 0.17
tetra-pentaPBDE 127 0.009 ± 0.06 0.35 ± 0.26 0.05 ± 0.16 0.035 ± 0.051
BDE-153 127 −0.25 ± 0.07* 0.01 ± 0.34 0.15 ± 0.20 0.072 ± 0.068
Multivariate modelc
di-ortho PCB 218 −0.07 ± 0.09 −0.19 ± 0.34 0.08 ± 0.21 −0.28 ± 0.089
mono-ortho PCB TEQ 218 −0.10 ± 0.07 0.09 ± 0.27 0.003 ± 0.17 −0.029 ± 0.065
PCDD/F TEQ 66 −0.54 ± 0.21* −0.43 ± 0.89 −0.01 ± 0.53 −0.18 ± 0.25
tetra-pentaPBDE 126 0.02 ± 0.06 −0.01 ± 0.21 0.14 ± 0.12 0.048 ± 0.052
BDE-153 126 −0.20 ± 0.08* −0.34 ± 0.37 0.17 ± 0.22 0.085 ± 0.076
aLn-transformed blood serum concentrations in late pregnancy; di-ortho PCB (sum of PCB 138, 153 and 180) and mono-ortho PCB TEQ (sum of TEQs for PCB 105,
118, 156 and 167) [32]. Ln-transformed mother’s milk concentrations of PCDD/F TEQ (sum of TEQs for the 17 congeners with WHO TEFs) [32], tetra-pentaPBDE
(sum of BDE-47, BDE-99, BDE-100) and BDE-153
ba-TPO data were ln-transformed in the statistical analyses due to a log-normal distribution
cAssociations adjusted for maternal age, pre-pregnancy BMI, smoking during pregnancy and season of sampling, *p ≤ 0.05
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Sweden. Results from other studies of PBDE exposure
and THs in pregnant women are difficult to compare
because of large differences in study design and expos-
ure levels. Among larger studies from North America
the results vary significantly, with one study showing an
inverse association between maternal serum lipid PBDE
(sum of BDE-28, −47, −99, −100 and −153) and third tri-
mester TSH concentrations, and three other studies
reporting varying associations with T3 and T4 but no
associations with TSH [21, 22, 35]. PBDE body burdens
were about 10-fold higher among North American
women than among our study participants.
Many of the previous PBDE studies have only inves-
tigated maternal TH status at one time point during
pregnancy. However, Abdelouahab et al. [22] found a
confounder-adjusted inverse association between ma-
ternal plasma lipid BDE-47 and −99 concentrations in
US women and first trimester total T4, total T3, free
T4 and free T3 (not BDE-99), but these associations
did not persist at delivery except for BDE-47 and free
T4. BDE-153 was not included as a single congener
in the statistical analyses [22].
Chevrier [36] have discussed important factors to con-
sider in studies of thyroid hormones and PBDEs that
may be responsible for differences in results between
studies. These factors include iodine status, method for
lipid adjustment of PBDE concentrations in blood,
method used for analysis of free TH, presence of hydrox-
ylated PBDE metabolites and reverse causality [36]. We
propose that in future studies a prospective approach
should be used, with assessment of POP body burdens
starting before pregnancy and with repeated measure-
ment of maternal TH status during the whole study
period. Ideally repeated measurements of maternal POP
body burdens should also be included in order to deter-
mine if there are associations between changes in POP
body burdens and changes in TH status. Inclusion of a
broad battery of biochemical/functional markers of
thyroid system function, as well as nutritional status
(iodine, selenium, etc.), would improve possibilities of
determining possible mechanisms of POP-induced
disruption of the thyroid system. The same study design
should be used on different cohorts around the world in
order to improve conclusions about causality of associa-
tions found.
The inverse BDE-153 association with maternal first
trimester total T3 observed by us did, in contrast to
the PCDD/F association [24], not persist into the
third trimester. There was no correlation between
PCDD/F and BDE-153 concentrations in mother’s
milk (Pearson’s r = 0.087, p = 0.41, N = 93). Neverthe-
less we investigated if associations with first trimester
total T3 were changed in a regression model with
both PCDD/F and BDE-153 included. In this case the
BDE-153 association was strengthened and remained statis-
tically significant (β = −0.28 ± 0.13, p = 0.035, N = 62),
whereas the PCDD/F association was slightly weakened
and became non-significant (β = −0.35 ± 0.23, p = 0.14; N =
62). Similarly the association between PCDD/F and third
trimester, reported in Darnerud et al. [24] (β = −0.32 ± 0.16,
p = 0.050, N = 91) was weakened and became non-
significant after adjustment for BDE-153 (β = −0.30 ± 0.17,
p = 0.087, N = 87). In this case the BDE-153 association
with third trimester T3 remained non-significant (results
not shown). The results suggest that although there was no
Table 5 Regression coefficients (β, mean ± standard error) for associations between maternal body burdens of PBDEs and
concentrations of thyroid hormones in infants at 3 weeks and 3 months of age
Body burdena 3 weeks 3 months
Total T3 Free T4 TSH Total T3 Free T4 TSH
Unadjusted model
tetra-pentaPBDE 0.01 ± 0.03 −0.20 ± 0.28 0.004 ± 0.04 0.02 ± 0.02 0.14 ± 0.29 0.02 ± 0.04
BDE-153 0.03 ± 0.11 −0.36 ± 0.40 0.16 ± 0.19 0.14 ± 0.10 −0.33 ± 0.41 0.28 ± 0.17
Multivariate modelb
tetra-pentaPBDE 0.03 ± 0.03 −0.12 ± 0.30 0.02 ± 0.05 0.03 ± 0.03 −0.04 ± 0.30 0.03 ± 0.03
BDE-153 0.11 ± 0.11 −0.48 ± 0.42 0.01 ± 0.20 0.19 ± 0.11 −0.47 ± 0.44 0.15 ± 0.18
aLn-transformed mother’s milk concentrations of tetra-pentaPBDE (sum of BDE-47, BDE-99 and BDE-100) and BDE-153 (N = 104-130)
bAssociations adjusted for maternal age, pre-pregnancy BMI, smoking, alcohol consumption, infant’s sex and birth weight. *p ≤ 0.05
Table 4 Regression coefficients (β, mean ± standard error) for
associations between maternal body burdens of PBDEs and
third trimester concentrations of thyroid hormones
Body burdensa Total T3 Free T4 TSH
Unadjusted model
tetra-pentaPBDE 0.03 ± 0.05 0.22 ± 0.11 −0.13 ± 0.09
BDE-153 −0.06 ± 0.06 0.08 ± 0.16 0.04 ± 0.12
Multivariate modelb
tetra-pentaPBDE −0.005 ± 0.04 0.19 ± 0.11 −0.06 ± 0.08
BDE-153 0.03 ± 0.06 −0.02 ± 0.16 −0.03 ± 0.13
aLn-transformed mother’s milk concentrations of tetra-pentaPBDE (sum of
BDE-47, BDE-99 and BDE-100) and BDE-153 (N = 166)
bAssociations adjusted for maternal age, pre-pregnancy BMI, smoking during
pregnancy, season of sampling and weight gain during pregnancy. *p ≤ 0.05
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significant correlation between mother’s milk lipid PCDD/F
and BDE-153 concentrations, there may be some shared
variance that explains some of the observed associations
with total T3.
We can only speculate why there were differences in
association between BDE-153 and total T3 in the first
(inverse association) and third trimester (no association),
when associations between PCDD/Fs and total T3 were
more consistent (inverse at both occasions). Large
physiological changes occur between first and third tri-
mesters, and the demand on the maternal thyroid
system most probably also changes. During the first
trimester, fetal development is dependent on maternal
thyroid status, whereas later in pregnancy fetal thyroid
function takes over. It may be possible that there are
first and third trimester differences in the capacity of the
maternal thyroid system to compensate for POP disrup-
tion. In fact the association between PCDD/F and total
T3 appeared to be stronger in early pregnancy than in
later pregnancy, as suggested by a lower β coefficient for
the association in the third trimester (β = −0.32) [24]
than in the first trimester (β = −0.54) (present study).
Mother’s milk lipid concentrations of PCDD/Fs and
PBDEs were used by us as a measure of maternal body
burden during pregnancy, which makes it difficult to
draw conclusions about causality of observed associa-
tions. Reverse causality may be possible since maternal
T3 status could have influenced distribution, metabolism
and excretion of the contaminants. For instance, mam-
mary gland transfer of the contaminants from maternal
blood into mother’s milk may be affected by TH status.
Moreover, maternal serum lipid concentrations of the
contaminants may be affected, thus indirectly influen-
cing the mother’s milk concentrations. We could not
find published studies on influences of maternal TH sta-
tus on mammary gland PCDD/F and PBDE transfer.
Several observations do however suggest that TH status
does not influence transfer of POPs to mother’s milk,
such as a positive correlation (Pearson’s r = 0.98) between
serum lipid and mother’s milk lipid BDE-153 concentra-
tions 3 weeks after delivery in the POPUP cohort [37],
and a positive correlation between maternal third trimes-
ter serum lipid di-ortho PCB concentrations and mothers
milk lipid di-ortho PCB concentrations (Pearson’s r = 0.93;
N = 202) among POPUP mothers with both matrices ana-
lysed. Transfer of lipid soluble PCDD/Fs, PCBs and
PBDEs from maternal blood to mother’s milk is most
likely a passive process, although it varies depending on
the lipid solubility of the contaminants, number of chlo-
rines in the molecule, and molecular weight and volume
[38]. The possibility the maternal TH status influences
maternal serum lipid POP concentrations is not supported
by the lack of associations between maternal first (the
present study) and third trimester [24] TH status and
maternal serum lipid mono- and di-ortho PCB concentra-
tions. Moreover, a strong positive intra-individual correl-
ation in di-ortho PCB concentrations during pregnancy
has been found [39, 40], suggesting that physiological
changes during pregnancy do not bias serum lipid POP
concentrations in late pregnancy compared to concentra-
tions before pregnancy or in early pregnancy.
The mean decrease in first trimester concentrations of
total T3 was 0.54 nmol/L (95 % confidence interval:
0.13-0.95) for every 1-unit increase in ln-transformed
mother’s milk lipid PCDD/F TEQ concentration. This
corresponds to a mean difference in total T3 of approxi-
mately 0.3 nmol/L between the 25th (5.8 pg TEQ/g
lipid) and 75th (9.7 pg TEQ/g lipid) percentile of PCDD/
F TEQ body burdens. The median first trimester total
T3 concentration was 2.4 nmol/L, and total T3 normally
is relatively stable over time [41]. Consequently our
observed PCDD/F-induced change, if causal, could be
viewed as a significant shift in total T3 status during the
first trimester when the fetus is dependent on maternal
TH status. It may however be argued that it would be
more relevant to measure free T3 concentrations in
serum than total T3, since free T3 is the biologically
available fraction of total T3. In the previous study when
THs in late pregnancy were analysed, total T3, free T4
and TSH were regarded as the most relevant THs to
measure [24], since a method for measuring free T3 was
not available in the laboratory. This was also the case a
few years later when THs in early pregnancy were
analysed.
The developing fetus is dependent on maternal thyroid
status during the first 20 weeks of gestation [36]. Our
findings of inverse associations between maternal
PCDD/F or PBDE-153 body burdens and circulating
total T3 in week 6–12 may have implications for normal
fetal development. Recent studies show that extracellular
T3 may act via pathways mediated by for instance integ-
rin hormone receptor domains in the apical membranes
of many types of cells [42]. Further studies of possible
involvement of T3 in regulation of physiological function
through such extracellular pathways are needed before
conclusions may be drawn about the significance of
PCDD/F- and PBDE-induced alterations in T3 status for
human health.
In the present investigation, no significant associa-
tions were observed between prenatal exposure to
PBDEs and infant concentrations of THs [24]. Among
other studies on PBDE exposure and infant TH con-
centrations some studies have been small or have
reported unadjusted correlations [43–47]. Larger stud-
ies, taking possible confounding of PBDE and TH
associations into account [14, 17–20], have reported
inverse, positive, as well as no significant associations
between PBDE exposure and THs in infant serum or
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cord blood. This further illustrates the difficulties in
interpreting the significance of the findings reported
in POP/TH research [36].
It could be argued that a large portion of the PBDE
exposure of infants occurs after birth through breast
feeding. To assess if this route of PBDE exposure may
have influenced infant TH status at 3 months of age we
estimated mother’s milk exposure by multiplying PBDE
concentrations in mother’s milk (ng/g fresh weight)
with number of days of full breast feeding during the
first 3 months of life. In this case a day with reported
partial breastfeeding was accounted for as ½ day of full
feeding. We did not observe significant associations
between mother’s milk exposure to tetra-pentaPBDE
and TSH (β = 0.00053 ± 0.0029; mean ± SE; p = 0.85; N =
101), free T4 (β = −0.013 ± 0.020; p = 0.54; N = 101) and
total T3 (β = −0.00047 ± 0.0020; p = 0.79; N = 101), after
adjusting for maternal age, maternal pre-pregnancy BMI,
maternal smoking, maternal alcohol consumption, infant
sex and birth weight. Similarly no associations were
observed between mother’s milk exposure to BDE-153
and TSH (β = −0.023 ± 0.028; p = 0.41; N = 101), free
T4 (β = −0.19 ± 0.20; p = 0.36; N = 101) and free T4
(β = −0.027 ± 0.017; p = 0.12; N = 101). Similarly, in
the previous study we did not observe significant associa-
tions between mother’s milk exposure to PCDD/Fs and
PCBs and infant TH status at 3 months of age [24].
We did not find any significant associations
between PCDD/F, PCB and PBDE body burdens and
third trimester maternal serum anti-TPO concentra-
tions, suggesting that the POPs at background
concentrations in Sweden do not induce thyroid dys-
function in pregnant women by the anti-TPO mecha-
nisms. Our finding of no associations with PCBs is in
agreement with a study of adults in Italy [27]. In a
study of adults living in a highly PCB polluted area and
in two less polluted areas of Slovakia, the highly
exposed population had a higher frequency of a posi-
tive test for anti-TPO [26].
The main strengths of the present study are the
relatively large sample size, the adjustment of results
for possible confounding, and the availability of
maternal and infant TH from two time periods. How-
ever, we cannot exclude the possibility that the
observed associations with PCDD/Fs and BDE-153
may be a result of residual confounding. For example,
we did not have data on iodine and selenium status
of the participating mothers. Moreover, because of the
cross-sectional design of the study, it is not possible
to draw conclusions about causality of the PCDD/F
and BDE-153 results, although the lack of associations
for PCBs and other PBDEs suggests that maternal TH
status in general does not affect serum and mother’s
milk concentrations of lipid soluble POPs.
Conclusions
We found that higher maternal body burdens of PCDD/
Fs and BDE-153 were associated with lower concentra-
tions of first trimester total T3 in this Swedish cohort.
The present study shows that BDE-association did not
persist into the third trimester, whereas our previous
study shows that the PCDD/F association does [24]. Tak-
ing both the PBDE results in the present study and the
PCDD/F results in the previous study into account, the
observed maternal associations were not mirrored in the
infants, suggesting that POP-induced changes in mater-
nal TH status do not necessarily result in significant
changes in infant TH status. The large variation in study
design of previously published studies makes it difficult
to compare results. In order to reach more certain con-
clusions about causality of associations between POP-
exposure and maternal/infant TH status, prospective
studies with repeated measurements of a wide range of
biochemical/functional markers of TH status and POPs
before, during and after pregnancy should be performed
on maternal/infant cohorts from different parts of the
world.
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